CARLOS ELIZONDO: Open Payments
NPI 1417391764 · ALICE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,598 in 112 payments from 27 companies in 2025. Trend: 2023 $2,327 · 2024 $2,886 · 2025 $2,598
Food & beverage: $2,598
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $702 |
| Sumitomo Pharma America, Inc. | 15 | $323 |
| Lilly USA, LLC | 9 | $222 |
| Merck Sharp & Dohme LLC | 9 | $180 |
| SCPHARMACEUTICALS INC. | 5 | $125 |
| Nalu Medical, Inc. | 1 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $83 |
| PFIZER INC. | 4 | $83 |
| Lundbeck LLC | 3 | $73 |
| Medtronic, Inc. | 2 | $67 |
Products named: Ozempic, GEMTESA, Wegovy, KISUNLA, FUROSCIX, VERQUVO, Nalu Neurostimulation System, MOUNJARO.
Industry payments across TX — which companies pay providers there.
